Skip to main content

ERA4Health - Fostering a European Research Area for Health

With the aim of funding and implementing joint research and innovation programs in Europe in priority areas of public health and well-being, ERA4Health aims to establish flexible and effective coordination between funding agencies in the European Research Area. This partnership brings together the success and experience of several previous European initiatives, such as ERA-CVD, EuroNanoMed and various ERANet cofunds developed within the framework of the JPI HDHL.

ERA4Health currently brings together 37 organizations from 24 countries, such as ministries, national and regional funding agencies, an intergovernmental non-profit organization, research institutes and foundations.

The priority areas, described in its Strategic Research and Innovation Agenda, are divided into four main pillars: 1) Cardiovascular diseases; 2) Nanotechnologies and advanced technologies for disease prevention, diagnosis and therapy; 3) Diseases related to nutrition and lifestyles; and 4) Prevention and public health strategies.

FCT and the Agency for Clinical Research and Biomedical Innovation are the Portuguese organizations that are part of ERA4Health.

This initiative has received funding from the European Union's Horizon Europe research and innovation program, grant agreement No. 101095426.

Documents

Calls

See the Calls area on the FCT website for information on the Calls in this partnership with FCT participation.

Previous editions: 2022 - CARDINNOV; HealthEquity; 2024.